Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E de Jongh

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Frontiers in Oncology|July 12, 2021
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer PatientsI E de Kruijff, A M Sieuwerts, N Beije, et al.
Breast (Edinburgh, Scotland)|December 10, 2013
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' groupM E Hamaker, C Seynaeve, A N M Wymenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 studyK K H Goey, S G Elias, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2014
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patientsB Mostert, A M Sieuwerts, J Kraan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Frontiers in Oncology|July 12, 2021
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer PatientsI E de Kruijff, A M Sieuwerts, N Beije, et al.
Breast (Edinburgh, Scotland)|December 10, 2013
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' groupM E Hamaker, C Seynaeve, A N M Wymenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 studyK K H Goey, S G Elias, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2014
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patientsB Mostert, A M Sieuwerts, J Kraan, et al.
Pageof 2